Abbey Labs application seeks higher-dose florfenicol use in Tasmanian salmon farming
Published · Updated
What happened
Abbey Labs disclosed on 2026-10-30 that a federal regulator is assessing a new application to permit higher-dose florfenicol use in Tasmanian salmon farming and across a wider area than before. The application follows a previous permit revocation linked to residues detected in wild fish and abalone.
Why it matters
The regulator now has an active file that could change antibiotic use settings in a major aquaculture industry. Any approval, restriction or public pushback could affect seafood market access, compliance costs for producers, and confidence in environmental monitoring and residue controls.
A new application disclosed on 2026-10-30 asks the federal regulator to allow higher-dose use of florfenicol in Tasmanian salmon farming and over a wider operating area. The filing revives a live policy issue because an earlier permit was revoked after residue concerns in wild fish and abalone. The matter now sits at the intersection of aquaculture regulation, export market confidence, environmental oversight and Commonwealth-state coordination.
Watch for
Australian Pesticides and Veterinary Medicines Authority publication of the Abbey Labs application status or consultation materials by 2026-11-02 Tasmanian EPA statement on monitoring, permit interaction, or environmental conditions for salmon lease areas by 2026-11-02 Australian Department of Agriculture, Fisheries and Forestry clarification on export certification or residue compliance implications by 2026-11-02 No APVMA notice of interim approval or variation for florfenicol by 2026-11-02
Researched and written by AI from the sources listed, under published rules. How V³ Aware is made